-
公开(公告)号:US20050090534A1
公开(公告)日:2005-04-28
申请号:US10505742
申请日:2003-02-27
申请人: Nozomu Sakai , Yu Momose , Katsuhito Murase , Masatoshi Hazama
发明人: Nozomu Sakai , Yu Momose , Katsuhito Murase , Masatoshi Hazama
IPC分类号: A61P3/10 , A61P25/00 , A61P25/24 , A61P43/00 , C07D263/32 , C07D263/38 , C07D263/46 , C07D263/48 , C07D277/28 , C07D277/30 , C07D277/40 , C07D277/46 , C07D413/04 , C07D413/06 , C07D413/12 , C07D413/14 , C07D417/04 , C07D417/14 , C07F9/653 , C07F9/6539 , C07D417/02 , A61K31/4178 , A61K31/422 , A61K31/427 , C07D413/02 , C07D43/02
CPC分类号: C07D413/04 , C07D263/32 , C07D263/38 , C07D263/46 , C07D263/48 , C07D277/30 , C07D277/40 , C07D277/46 , C07D413/06 , C07D413/12 , C07D413/14 , C07D417/04 , C07D417/14 , C07F9/653 , C07F9/6539
摘要: The present invention provides a compound represented by the formula (I) wherein R1 is a hydrogen atom, a halogen atom, an optionally substituted hydrocarbon group, an optionally substituted heterocyclic group, an optionally substituted hydroxy group, an optionally substituted thiol group or an optionally substituted amino group, A is an optionally substituted cyclic amino group or —NR2—W-D wherein R2 is a hydrogen atom or an alkyl group, W is a bond or a divalent acyclic hydrocarbon group, and D is an optionally substituted cyclic group, an optionally substituted amino group or an optionally substituted acyl group, B is an optionally substituted hydrocarbon group or an optionally substituted heterocyclic group, X is an oxygen atom, a sulfur atom or an optionally substituted nitrogen atom, and Y is a bond or a divalent acyclic hydrocarbon group, or a salt thereof, which is useful for the prophylaxis or treatment of diabetic neuropathy and the like.
摘要翻译: 本发明提供由式(I)表示的化合物,其中R 1为氢原子,卤素原子,任选取代的烃基,任选取代的杂环基,任选取代的羟基, 任选取代的硫醇基或任选取代的氨基,A是任选取代的环氨基或-NR 2 -WD,其中R 2是氢原子或烷基 基团,W是键或二价无环烃基,D是任选取代的环状基团,任选取代的氨基或任选取代的酰基,B是任选取代的烃基或任选取代的杂环基,X是 氧原子,硫原子或任选取代的氮原子,Y是可用于预防或治疗糖尿病性神经病变等的键或二价无环烃基或其盐。
-
公开(公告)号:US07183276B2
公开(公告)日:2007-02-27
申请号:US10505742
申请日:2003-02-27
申请人: Nozomu Sakai , Yu Momose , Katsuhito Murase , Masatoshi Hazama
发明人: Nozomu Sakai , Yu Momose , Katsuhito Murase , Masatoshi Hazama
IPC分类号: A61K31/5377 , A61K31/421 , A61K31/454 , A61K31/541 , C07D413/04 , C07D279/12 , C07F9/653 , C07D211/46
CPC分类号: C07D413/04 , C07D263/32 , C07D263/38 , C07D263/46 , C07D263/48 , C07D277/30 , C07D277/40 , C07D277/46 , C07D413/06 , C07D413/12 , C07D413/14 , C07D417/04 , C07D417/14 , C07F9/653 , C07F9/6539
摘要: The present invention provides a compound represented by the formula (I) wherein R1 is a hydrogen atom, a halogen atom, an optionally substituted hydrocarbon group, an optionally substituted heterocyclic group, an optionally substituted hydroxy group, an optionally substituted thiol group or an optionally substituted amino group, A is an optionally substituted cyclic amino group or —NR2—W—D wherein R2 is a hydrogen atom or an alkyl group, W is a bond or a divalent acyclic hydrocarbon group, and D is an optionally substituted cyclic group, an optionally substituted amino group or an optionally substituted acyl group, B is an optionally substituted hydrocarbon group or an optionally substituted heterocyclic group, X is an oxygen atom, a sulfur atom or an optionally substituted nitrogen atom, and Y is a bond or a divalent acyclic hydrocarbon group, or a salt thereof, which is useful for the prophylaxis or treatment of diabetic neuropathy and the like.
摘要翻译: 本发明提供由式(I)表示的化合物,其中R 1为氢原子,卤素原子,任选取代的烃基,任选取代的杂环基,任选取代的羟基, 任选取代的硫醇基或任选取代的氨基,A是任选取代的环氨基或-NR 2 -WD,其中R 2是氢原子或烷基 基团,W是键或二价无环烃基,D是任选取代的环状基团,任选取代的氨基或任选取代的酰基,B是任选取代的烃基或任选取代的杂环基,X是 氧原子,硫原子或任选取代的氮原子,Y是可用于预防或治疗糖尿病性神经病变等的键或二价无环烃基或其盐。
-
公开(公告)号:US20080269219A1
公开(公告)日:2008-10-30
申请号:US12080461
申请日:2008-04-03
申请人: Yu Momose , Katsuhito Murase
发明人: Yu Momose , Katsuhito Murase
IPC分类号: A61K31/5377 , A61K31/421 , A61K31/426 , A61K31/4525 , A61P25/00 , A61P1/00 , A61P29/00 , A61K31/496 , A61K31/443 , A61K31/506
CPC分类号: C07D263/34 , C07D231/12 , C07D233/56 , C07D249/08 , C07D263/38 , C07D263/46 , C07D263/48 , C07D277/32 , C07D277/40 , C07D277/54 , C07D413/04 , C07D413/12 , C07D417/04 , C07D417/14
摘要: A neurotrophin production/secretion promoting agent which comprises an azole derivative of the formula: wherein R1 represents a halogen atom, a heterocyclic group which may optionally be substituted, a hydroxy group which may optionally be substituted, a thiol group which may optionally be substituted, or an amino group which may optionally be substituted; A represents an acyl group which may optionally be substituted, a heterocyclic group which may optionally be substituted, a hydroxy group which may optionally be substituted, or a carboxyl group which may optionally be esterified or amidated; B represents an aromatic group which may optionally be substituted; X represents oxygen atom, sulfur atom, or nitrogen atom which may optionally be substituted; and Y represents a divalent hydrocarbon group or heterocyclic group, or a salt thereof; which is useful as an agent for preventing or treating neuropathy.
摘要翻译: 神经营养蛋白产生/分泌促进剂,其包含下式的唑衍生物:其中R 1表示卤素原子,可任选被取代的杂环基,可任选被取代的羟基, 可以任选被取代的硫醇基,或可任意被取代的氨基; A表示可任选被取代的酰基,可任选被取代的杂环基,可任意取代的羟基或可任意被酯化或酰胺化的羧基; B表示可任选被取代的芳族基团; X表示可任选被取代的氧原子,硫原子或氮原子; Y表示二价烃基或杂环基,或其盐; 其可用作预防或治疗神经病的药剂。
-
公开(公告)号:US06605629B1
公开(公告)日:2003-08-12
申请号:US09868304
申请日:2001-06-29
申请人: Yu Momose , Katsuhito Murase
发明人: Yu Momose , Katsuhito Murase
IPC分类号: C07D41312
CPC分类号: C07D263/34 , C07D231/12 , C07D233/56 , C07D249/08 , C07D263/38 , C07D263/46 , C07D263/48 , C07D277/32 , C07D277/40 , C07D277/54 , C07D413/04 , C07D413/12 , C07D417/04 , C07D417/14
摘要: A neurotrophin production/secretion promoting agent which comprises an azole derivative of the formula: wherein R1 represents a halogen atom, a heterocyclic group which may optionally be substituted, a hydroxy group which may optionally be substituted, a thiol group which may optionally be substituted, or an amino group which may optionally be substituted; A represents an acyl group which may optionally be substituted, a heterocyclic group which may optionally be substituted, a hydroxy group which may optionally be substituted, or a carboxyl group which may optionally be esterified or amidated; B represents an aromatic group which may optionally be substituted; X represents oxygen atom, sulfur atom, or nitrogen atom which may optionally be substituted; and Y represents a divalent hydrocarbon group or heterocyclic group, or a salt thereof; which is useful as an agent for preventing or treating neuropathy.
摘要翻译: 一种神经营养因子产生/分泌促进剂,其包含下式的唑衍生物:其中R1表示卤素原子,可任意取代的杂环基,可任选被取代的羟基,可任选被取代的硫醇基, 或可任选被取代的氨基; A表示可任选被取代的酰基,可任选被取代的杂环基,可任意取代的羟基或可任意被酯化或酰胺化的羧基; B表示可任选被取代的芳族基团; X表示可任选被取代的氧原子,硫原子或氮原子; Y表示二价烃基或杂环基,或其盐; 其可用作预防或治疗神经病的药剂。
-
公开(公告)号:US07396848B1
公开(公告)日:2008-07-08
申请号:US10616769
申请日:2003-07-10
申请人: Yu Momose , Katsuhito Murase
发明人: Yu Momose , Katsuhito Murase
IPC分类号: A61K31/42 , A61K31/415
CPC分类号: C07D263/34 , C07D231/12 , C07D233/56 , C07D249/08 , C07D263/38 , C07D263/46 , C07D263/48 , C07D277/32 , C07D277/40 , C07D277/54 , C07D413/04 , C07D413/12 , C07D417/04 , C07D417/14
摘要: A neurotrophin production/secretion promoting agent which comprises an azole derivative of the formula: wherein R1 represents a halogen atom, a heterocyclic group which may optionally be substituted, a hydroxy group which may optionally be substituted, a thiol group which may optionally be substituted, or an amino group which may optionally be substituted; A represents an acyl group which may optionally be substituted, a heterocyclic group which may optionally be substituted, a hydroxy group which may optionally be substituted, or a carboxyl group which may optionally be esterified or amidated; B represents an aromatic group which may optionally be substituted; X represents oxygen atom, sulfur atom, or nitrogen atom which may optionally be substituted; and Y represents a divalent hydrocarbon group or heterocyclic group, or a salt thereof; which is useful as an agent for preventing or treating neuropathy.
-
公开(公告)号:US20090156582A1
公开(公告)日:2009-06-18
申请号:US11884054
申请日:2006-02-09
申请人: Tetsuya Tsukamoto , Takeshi Yamamoto , Ryosuke Tokunoh , Tomohiro Kawamoto , Masahiro Okura , Masakumi Kori , Katsuhito Murase
发明人: Tetsuya Tsukamoto , Takeshi Yamamoto , Ryosuke Tokunoh , Tomohiro Kawamoto , Masahiro Okura , Masakumi Kori , Katsuhito Murase
IPC分类号: A61K31/55 , A61K31/454 , A61K31/4162 , C07D403/02
CPC分类号: C07D231/38 , C07D401/12 , C07D403/12 , C07D405/12 , C07D405/14
摘要: The present invention provides a pyrazole compound represented by the formula (I): wherein ring A0 is a pyrazole ring optionally further having 1 or 2 substituents; Ra is a substituted carbamoyl group; and Rb is an optionally substituted acylamino group, or a salt thereof or a prodrug thereof, which is useful as an agent for the prophylaxis or treatment of GSK-3β related pathology or disease, and a GSK-3β inhibitor including same.
摘要翻译: 本发明提供由式(I)表示的吡唑化合物:其中环A0是任选还含有1或2个取代基的吡唑环; Ra是取代的氨基甲酰基; 和Rb是可用作预防或治疗GSK-3β相关病理学或疾病的药剂的任选取代的酰基氨基或其盐或其前药,以及包含GSK-3β抑制剂的GSK-3β抑制剂。
-
公开(公告)号:US08492378B2
公开(公告)日:2013-07-23
申请号:US12309906
申请日:2007-08-02
申请人: Fumio Itoh , Jun Kunitomo , Hiromi Kobayashi , Eiji Kimura , Morihisa Saitoh , Tomohiro Kawamoto , Hiroki Iwashita , Katsuhito Murase
发明人: Fumio Itoh , Jun Kunitomo , Hiromi Kobayashi , Eiji Kimura , Morihisa Saitoh , Tomohiro Kawamoto , Hiroki Iwashita , Katsuhito Murase
IPC分类号: A61K31/535
CPC分类号: C07D413/04 , C07D413/14 , C07D417/04 , C07D471/04 , C07D487/04 , C07D491/048 , C07D495/04 , C07D513/04
摘要: For the purpose of providing a GSK-3β inhibitor containing an oxadiazole compound or a salt thereof or a prodrug thereof useful as an agent for the prophylaxis or treatment of a GSK-3β-related pathology or disease, the present invention provides a GSK-3β inhibitor containing a compound represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof or a prodrug thereof.
摘要翻译: 为了提供含有恶二唑化合物或其盐的GSK-3β抑制剂或其用作预防或治疗GSK-3β相关病理或疾病的药物的前药,本发明提供了GSK-3β 含有由式(I)表示的化合物的抑制剂:其中每个符号如说明书中所定义,或其盐或其前药。
-
-
-
-
-
-